Search filters

Filters
Clear All

Phase

  • 3
  • 4
  • 3
  • 6
  • 2
  • 11
  • 2
  • 38
  • 71
  • 22
  • 4
  • 67

Found 71 Menstruation trials

A listing of Menstruation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years - 80 years
All genders
Phase 3
This study will be a randomized, subject and evaluator blinded, controlled, multicenter trial conducted to evaluate the safety and efficacy NTX-001 compared to standard of care (neurorrhaphy) in the treatment of upper extremity transected nerves requiring surgical repair. The study will be conducted in approximately 25-30 sites in the US …
18 years - 75 years
All genders
Phase 3
Study is designed to evaluate the efficacy and safety of brenipatide in adults with moderate-to-severe alcohol use disorder (AUD). This study will investigate the effects of brenipatide across a wide dose range to inform further clinical development of the molecule for the treatment of AUD.
18 years - 60 years
Accepts healthy volunteer
All genders
The purpose of this research is to study how regular cannabis use may affect brain function and cognition in individuals with cannabis use disorder. The study will use two types of imaging to structurally and functionally analyze the brain. We will use MRI scans to study the brain. MRI scans use …
18 years - 99 years
Female
Interventional
This study investigates the recovery process in women who have undergone Pelvic Organ Prolapse (POP) surgery. Participants will be evaluated using a self-reported recovery questionnaire and will wear an accelerometer on their wrist to monitor activity levels.The study evaluates whether a prescribed exercise regimen after surgery can lead to quicker …
Biomechanical outcomes of a molded ankle foot orthosis (MAFO) in patients with Achilles tendinopathy
18 years - 65 years
All genders
This study will investigate the implications of loading on Achilles tendon health. To do this, we will evaluate Achilles tendon structure and function using ultrasound imaging, motion analysis, and wearable sensors.
HORIZON OLE
99 years or below
All genders
Phase 3
This is an open-label, single arm, multicenter extension study for participants with established CVD and elevated Lp(a) who completed the parent study. The purpose of this study is to assess the long-term safety and tolerability of pelacarsen (TQJ230). The study consists of: Screening period (up to approximately 30 days) and …
UPCC 12420 A Phase 2, Open- Label, Single-Arm, Multicohort, Multicenter Trial to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects with Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma (NHL)
18 years or above
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with relapsed or refractory indolent B-cell Non-Hodgkin Lymphoma (NHL), specifically follicular lymphoma (FL) and marginal zone lymphoma (MZL). The purpose of this study is to understand how well the investigational medication works in treating these types of …
99 years or below
All genders
PURPOSE We would like to accrue patients consecutively over a several year period in order to collect tissue from many histopathologic subsets of nervous system tumors. Primary brain tumors occur nationally at a rate of approximately 17,000 new cases annually and within this group there are numerous subtypes. At the …
99 years or below
All genders
A5385 is a two-step non-interventional study for participants from qualifying ACTG and non-ACTG interventional cure trials (parent studies) that include an analytical treatment interruption (ATI) period who achieved prolonged viral control off antiretroviral therapy (ART) post-intervention (post-intervention control [PIC]) in their parent study.
THRIVE
22 years - 75 years
All genders
THRIVE is an international, multicenter, 2:1 randomized, double blind, sham-controlled study, designed to demonstrate the adjunctive effectiveness and safety of the Therapeutic Intravascular Ultrasound (TIVUS) Renal Denervation System in hypertensive subjects while subjects are maintained off-antihypertensive medications for a 4-week wash-out period before RDN/Sham procedure and 2 months after procedure.